VPG Reports - Pharmaceuticals and Healthcare

(0) items in cart / view cart / checkout



	Aerospace and Defense
	Automotive
	Chemicals
	Consumer Packaged Goods
	Energy and Utilities
	Financial Services
	Geography
	Government and Non-Profit Organisations
	Industrial Goods and Machinery
	Ingredients
	Knowledge Center
	Leisure and Arts
	Media
	Paper and Packaging
	Pharmaceuticals and Healthcare
	Retailing
	ServiceLine
	Technology and Communications
	Textiles
	Transport and Logistics
	Wholesale

Home > Pharmaceuticals and Healthcare

Biotechnology - 74
Healthcare - 6
Medical Devices and Diagnostics - 4
Pharmaceuticals - 17

Pharmaceuticals and Healthcare market reports

Title

Published

Price

1 2 3 4 5 6 7 8 9 10 Next »

PharmaVitae: Company Comparator Tool Report Code: IMHC0080 The Comparator Tool builds from the PharmaVitae profiles of the 50 leading pharma...	02/29/2008	$45600.00

Stakeholder Insight: Acute Coronary Syndromes Fresh look at ACS in Europe, what is the real picture? Report Code: DMHC2347 The face of ACS is changing. The ageing population and pressure of growing risk...	12/26/2007	$30400.00

Commercial and Pipeline Insight: Influenza Vaccines - Pandemic threat revitalizes the sector Report Code: DMHC2280 The influenza vaccine market, sized at approximately $2.2 billion in 2006, yields many...	04/06/2007	$15200.00

Pipeline/Commercial Insight: Supportive Care in Oncology - Significant growth opportunities exist in new supportive care indications Report Code: DMHC2297 Supportive care can be defined as those products used to prevent and/or treat the...	06/15/2007	$15200.00

Commercial Insight: Depression - Atypical lifecycle management strategy rejuvenates depression market Report Code: DMHC2305 Novel pipeline drugs, lifecycle management of the current branded antidepressants, and...	06/27/2007	$15200.00

Commercial Insight: Insomnia - Strong brand identity critical to differentiation in an increasingly crowded market Report Code: DMHC2306 Ambien has remained the clear leader in the insomnia market for over a decade, with...	06/27/2007	$15200.00

Commercial Insight: Multiple Sclerosis - Continued growth makes the MS market a highly attractive investment Report Code: DMHC2307 The dynamic MS market continues to grow unabated; seven major market revenues...	06/27/2007	$15200.00

Commercial Insight: Osteoporosis - Risk management and reformulation offer best defense against generic onslaught Report Code: DMHC2308 The osteoporosis market is due a major upheaval when market leader Fosamax...	06/27/2007	$15200.00

Commercial Insight: Top 20 Cancer Therapy Brands - Sales of targeted therapies overtake cytotoxics in 2006 Report Code: DMHC2299 Sales of the Top 20 cancer therapy brands in each of the seven major markets totaled...	07/02/2007	$15200.00

Commercial Insight: Asthma & COPD - Combination products still have blockbuster potential Report Code: DMHC2310 Detailed analysis of the Asthma and COPD market. 10 year sales forecast for all major...	07/11/2007	$15200.00

Commercial Insight: HIV - Reshaping Treatment Paradigms Report Code: DMHC2311 Detailed analysis of the antiretroviral therapy market. 10 year sales forecast for...	07/11/2007	$15200.00

Commercial Insight: Antidyslipidemics - The competitive cost-conscious antidyslipidemics market presents challenges Report Code: DMHC2315 The restrictive, highly competitive antidyslipidemic market is going to become even...	07/11/2007	$15200.00

Pipeline/Commercial Insight: Antihypertensives New class opportunity offset by key patent expiries Report Code: DMHC2314 Datamonitor expects the antihypertensives market to reach almost $40 billion, across...	07/12/2007	$15200.00

Commercial and Pipeline Insight: Pediatric and Adolescent Vaccines - Substantial market expansion ahead Report Code: DMHC2313 The pediatric and adolescent vaccines market encompasses many different classes. DTP...	07/23/2007	$15200.00

R&D Strategies: Incremental improvements and paradigm shifts in strategy are both necessary to boost productivity Report Code: DMHC2309 Waves of technological advancements have powered significant evolution in R&D from...	08/09/2007	$15200.00

Launch Strategies - Analyzing Market Trends and Regulatory Impacts Report Code: DMHC2304 With fewer truly novel products entering the market, combined with increasing...	08/22/2007	$15200.00

Commercial Insight: Antidiabetics - Safety becomes the critical factor for success Report Code: DMHC2317 The diabetes epidemic has contributed in the growth of the antidiabetics market the...	08/23/2007	$15200.00

Commercial and Pipeline Insight: Hospital Antibacterials - A market beyond MRSA Report Code: DMHC2293 The Hospital antibacterials market accounted for $9.9bn of the total $41bn...	08/24/2007	$15200.00

1 2 3 4 5 6 7 8 9 10 Next »


VPGDataMonitor.com © Copyright 2008. all rights reserved.		Web Design by Spida Design